Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED
Company Information for

CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED

Building 5 Foundation Park, Roxborough Way, Maidenhead, BERKSHIRE, SL6 3UD,
Company Registration Number
07596438
Private Limited Company
Active

Company Overview

About Convergence Pharmaceuticals Holdings Ltd
CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED was founded on 2011-04-07 and has its registered office in Maidenhead. The organisation's status is listed as "Active". Convergence Pharmaceuticals Holdings Limited is a Private Limited Company registered in ENGLAND with Companies House and the accounts submission requirement is categorised as DORMANT
  • Company is not active ie not engaged in any business activity or receiving income or profits
  • Is not incurring costs other than: Annual return fee, late filing fees, companies house admin fees eg company name change or share payments
  • Holds no assets capable of producing any profits or income
  • Holds assets that are unlikely to produce profits and income in the near future
  • Investment trusts, pensions and client account companies may show as dormant companies as they are non trading
Key Data
Company Name
CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED
 
Legal Registered Office
Building 5 Foundation Park
Roxborough Way
Maidenhead
BERKSHIRE
SL6 3UD
Other companies in WC1V
 
Previous Names
NEWINCCO 1096 LIMITED04/08/2011
Filing Information
Company Number 07596438
Company ID Number 07596438
Date formed 2011-04-07
Country ENGLAND
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active
Lastest accounts 2024-12-31
Account next due 2026-09-30
Latest return 2025-11-24
Return next due 2026-12-08
Type of accounts DORMANT
Last Datalog update: 2026-01-14 22:33:57
Primary Source:Companies House
There are multiple companies registered at this address, the registered address may be the accountant's offices for CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED

Current Directors
Officer Role Date Appointed
STEVEN JOHN GREEN
Director 2018-04-12
TREVOR ANTHONY MILL
Director 2015-02-11
Previous Officers
Officer Role Date Appointed Date Resigned
SIMON NICHOLAS TATE
Director 2011-06-17 2018-04-12
DAVID JOHN WATSON
Director 2015-02-11 2018-04-12
BRENDA ELIZABETH REYNOLDS
Company Secretary 2011-06-17 2015-02-11
JOHN CHRISTOPHER ASTON
Director 2013-11-01 2015-02-11
CATHERINE ELIZABETH BINGHAM
Director 2011-10-26 2015-02-11
CLIVE JAMES DIX
Director 2011-06-17 2015-02-11
ALLAN PATRICK MARCHINGTON
Director 2012-07-25 2015-02-05
LIAM THOMAS RATCLIFFE
Director 2011-10-26 2015-02-05
JOHN CHRISTOPHER ASTON
Director 2013-11-01 2013-11-01
CHRISTOPHER HOLLOWOOD
Director 2011-10-26 2012-08-31
OLSWANG COSEC LIMITED
Company Secretary 2011-04-07 2011-06-17
CHRISTOPHER ALAN MACKIE
Director 2011-04-07 2011-06-17
OLSWANG DIRECTORS 1 LIMITED
Director 2011-04-07 2011-06-17
OLSWANG DIRECTORS 2 LIMITED
Director 2011-04-07 2011-06-17

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
STEVEN JOHN GREEN OLD CONVERGENCE PHARMACEUTICALS LIMITED Director 2018-04-12 CURRENT 2010-06-18 Active
STEVEN JOHN GREEN CONVERGENCE PHARMACEUTICALS LIMITED Director 2015-01-06 CURRENT 2015-01-06 Active
STEVEN JOHN GREEN SILVER ACQUISITION CO LIMITED Director 2014-12-19 CURRENT 2014-12-19 Active
STEVEN JOHN GREEN BIOGEN IDEC RESEARCH LIMITED Director 2011-08-11 CURRENT 2011-04-01 Active
TREVOR ANTHONY MILL OLD CONVERGENCE PHARMACEUTICALS LIMITED Director 2015-02-11 CURRENT 2010-06-18 Active
TREVOR ANTHONY MILL CONVERGENCE PHARMACEUTICALS LIMITED Director 2015-01-06 CURRENT 2015-01-06 Active
TREVOR ANTHONY MILL SILVER ACQUISITION CO LIMITED Director 2014-12-19 CURRENT 2014-12-19 Active
TREVOR ANTHONY MILL BIOGEN IDEC LIMITED Director 2012-04-16 CURRENT 1980-05-19 Active
TREVOR ANTHONY MILL BIOGEN IDEC RESEARCH LIMITED Director 2011-09-15 CURRENT 2011-04-01 Active

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2026-01-14CONFIRMATION STATEMENT MADE ON 24/11/25, WITH NO UPDATES
2024-06-26ACCOUNTS FOR DORMANT COMPANY MADE UP TO 31/12/23
2023-11-28Change of details for Silver Acquisition Co Limited as a person with significant control on 2023-11-28
2023-11-28CONFIRMATION STATEMENT MADE ON 24/11/23, WITH NO UPDATES
2023-10-23ACCOUNTS FOR DORMANT COMPANY MADE UP TO 31/12/22
2023-08-10REGISTERED OFFICE CHANGED ON 10/08/23 FROM 70 Norden Road Maidenhead Berkshire SL6 4AY
2023-06-19Director's details changed for Director Kylie Michele Bromley on 2023-06-16
2023-06-16APPOINTMENT TERMINATED, DIRECTOR LORI ELIZABETH MOCHAN
2023-06-16DIRECTOR APPOINTED GERONIMO MARTINEZ
2022-12-16FULL ACCOUNTS MADE UP TO 31/12/21
2022-12-16AAFULL ACCOUNTS MADE UP TO 31/12/21
2022-11-25CS01CONFIRMATION STATEMENT MADE ON 24/11/22, WITH NO UPDATES
2022-07-01AP01DIRECTOR APPOINTED DIRECTOR KYLIE MICHELE BROMLEY
2022-06-27TM01APPOINTMENT TERMINATED, DIRECTOR ALEXANDRA ISABELLA HANDRICH
2021-12-02CS01CONFIRMATION STATEMENT MADE ON 24/11/21, WITH NO UPDATES
2021-08-10AAFULL ACCOUNTS MADE UP TO 31/12/20
2020-12-10AAFULL ACCOUNTS MADE UP TO 31/12/19
2020-11-24CS01CONFIRMATION STATEMENT MADE ON 24/11/20, WITH UPDATES
2020-05-05AP01DIRECTOR APPOINTED LORI ELIZABETH MOCHAN
2020-05-05AP01DIRECTOR APPOINTED LORI ELIZABETH MOCHAN
2020-05-05TM01APPOINTMENT TERMINATED, DIRECTOR STEVEN JOHN GREEN
2020-05-05TM01APPOINTMENT TERMINATED, DIRECTOR STEVEN JOHN GREEN
2020-04-22SH19Statement of capital on 2020-04-22 GBP 1
2020-04-22SH19Statement of capital on 2020-04-22 GBP 1
2020-04-22RES13Resolutions passed:
  • Share premium account cancelled 08/04/2020
2020-04-22RES13Resolutions passed:
  • Share premium account cancelled 08/04/2020
2020-04-22SH20Statement by Directors
2020-04-22SH20Statement by Directors
2020-04-22CAP-SSSolvency Statement dated 08/04/20
2020-04-22CAP-SSSolvency Statement dated 08/04/20
2020-03-05CH01Director's details changed for Ms Helen Elizabeth Hanby on 2020-02-21
2020-03-05CH01Director's details changed for Ms Helen Elizabeth Hanby on 2020-02-21
2020-02-21AP01DIRECTOR APPOINTED MS HELEN ELIZABETH HANBY
2020-02-21AP01DIRECTOR APPOINTED MS HELEN ELIZABETH HANBY
2020-02-04TM01APPOINTMENT TERMINATED, DIRECTOR TREVOR ANTHONY MILL
2020-02-04TM01APPOINTMENT TERMINATED, DIRECTOR TREVOR ANTHONY MILL
2019-11-24CS01CONFIRMATION STATEMENT MADE ON 24/11/19, WITH NO UPDATES
2019-10-11AAFULL ACCOUNTS MADE UP TO 31/12/18
2018-11-26CS01CONFIRMATION STATEMENT MADE ON 24/11/18, WITH NO UPDATES
2018-10-06AAFULL ACCOUNTS MADE UP TO 31/12/17
2018-04-18AP01DIRECTOR APPOINTED STEVEN JOHN GREEN
2018-04-17TM01APPOINTMENT TERMINATED, DIRECTOR SIMON TATE
2018-04-17TM01APPOINTMENT TERMINATED, DIRECTOR DAVID WATSON
2017-12-04CS01CONFIRMATION STATEMENT MADE ON 24/11/17, WITH NO UPDATES
2017-10-06AAFULL ACCOUNTS MADE UP TO 31/12/16
2017-04-12AD02Register inspection address changed to 7 Albemarle Street London W1S 4HQ
2017-04-12AD03Registers moved to registered inspection location of 7 Albemarle Street London W1S 4HQ
2016-12-01LATEST SOC01/12/16 STATEMENT OF CAPITAL;GBP 22043.4425
2016-12-01CS01CONFIRMATION STATEMENT MADE ON 24/11/16, WITH UPDATES
2016-11-10AAFULL ACCOUNTS MADE UP TO 31/12/15
2015-12-17LATEST SOC17/12/15 STATEMENT OF CAPITAL;GBP 22043.4425
2015-12-17AR0124/11/15 ANNUAL RETURN FULL LIST
2015-08-17AAFULL ACCOUNTS MADE UP TO 31/12/14
2015-03-26AA01Previous accounting period shortened from 30/09/15 TO 31/12/14
2015-03-05LATEST SOC05/03/15 STATEMENT OF CAPITAL;GBP 22043.45
2015-03-05SH0111/02/15 STATEMENT OF CAPITAL GBP 22043.4500
2015-03-03AP01DIRECTOR APPOINTED MR DAVID WATSON
2015-03-03AP01DIRECTOR APPOINTED MR TREVOR ANTHONY MILL
2015-02-26SH0111/02/15 STATEMENT OF CAPITAL GBP 22043.44
2015-02-20TM02Termination of appointment of Brenda Elizabeth Reynolds on 2015-02-11
2015-02-20TM01APPOINTMENT TERMINATED, DIRECTOR ALLAN MARCHINGTON
2015-02-20TM01APPOINTMENT TERMINATED, DIRECTOR LIAM RATCLIFFE
2015-02-20TM01APPOINTMENT TERMINATED, DIRECTOR CATHERINE BINGHAM
2015-02-20TM01APPOINTMENT TERMINATED, DIRECTOR JOHN ASTON
2015-02-20TM01APPOINTMENT TERMINATED, DIRECTOR CLIVE DIX
2015-02-20TM01APPOINTMENT TERMINATED, DIRECTOR CLIVE DIX
2015-02-17AAFULL ACCOUNTS MADE UP TO 30/09/14
2015-02-12AD01REGISTERED OFFICE CHANGED ON 12/02/2015 FROM 90 HIGH HOLBORN LONDON WC1V 6XX
2014-12-17RES11DISAPPLICATION OF PRE-EMPTION RIGHTS
2014-12-17AR0124/11/14 FULL LIST
2014-09-22SH0131/07/14 STATEMENT OF CAPITAL GBP 20062.6900
2014-08-13RES13INC NOM CAP 08/07/2014
2014-08-13RES0108/07/2014
2014-06-20AR0107/04/14 FULL LIST
2014-04-07AA30/09/13 TOTAL EXEMPTION FULL
2014-02-10AP01DIRECTOR APPOINTED MR JOHN CHRISTOPHER ASTON
2014-01-09TM01APPOINTMENT TERMINATED, DIRECTOR JOHN ASTON
2013-11-14AP01DIRECTOR APPOINTED MR JOHN CHRISTOPHER ASTON
2013-05-29AR0107/04/13 FULL LIST
2013-01-15SH0121/12/12 STATEMENT OF CAPITAL GBP 15051.7160
2013-01-11AA30/09/12 TOTAL EXEMPTION FULL
2012-10-29AP01DIRECTOR APPOINTED ALLAN PATRICK MARCHINGTON
2012-10-19TM01APPOINTMENT TERMINATED, DIRECTOR CHRIS HOLLOWOOD
2012-05-02AR0107/04/12 FULL LIST
2012-01-18SH0130/11/11 STATEMENT OF CAPITAL GBP 10759.04
2012-01-11RES13SECTION 175 15/11/2011
2011-11-09AP01DIRECTOR APPOINTED LIAM RATCLIFFE
2011-11-09AP01DIRECTOR APPOINTED MRS CATHERINE ELIZABETH BINGHAM
2011-11-09AP01DIRECTOR APPOINTED CHRIS HOLLOWOOD
2011-11-09SH02SUB-DIVISION 27/10/11
2011-11-09RES12VARYING SHARE RIGHTS AND NAMES
2011-11-09RES01ADOPT ARTICLES 26/10/2011
2011-11-09SH0127/10/11 STATEMENT OF CAPITAL GBP 8659.26
2011-11-09SH08NOTICE OF NAME OR OTHER DESIGNATION OF CLASS OF SHARES
2011-11-09SH10NOTICE OF PARTICULARS OF VARIATION OF RIGHTS ATTACHED TO SHARES
2011-08-04NM06REQUEST TO SEEK COMMENTS OF GOVERNMENT DEPARTMENT OR OTHER SPECIFIED BODY ON CHANGE OF NAME
2011-08-04CERTNMCOMPANY NAME CHANGED NEWINCCO 1096 LIMITED CERTIFICATE ISSUED ON 04/08/11
2011-07-07TM02APPOINTMENT TERMINATED, SECRETARY OLSWANG COSEC LIMITED
2011-07-07TM01APPOINTMENT TERMINATED, DIRECTOR OLSWANG DIRECTORS 2 LIMITED
2011-07-07TM01APPOINTMENT TERMINATED, DIRECTOR OLSWANG DIRECTORS 1 LIMITED
2011-07-07TM01APPOINTMENT TERMINATED, DIRECTOR CHRISTOPHER MACKIE
2011-07-04AP01DIRECTOR APPOINTED CLIVE JAMES DIX
2011-07-04RES15CHANGE OF NAME 17/06/2011
2011-07-04CONNOTNOTICE OF CHANGE OF NAME NM01 - RESOLUTION
2011-07-04AA01CURREXT FROM 30/04/2012 TO 30/09/2012
2011-07-01AP01DIRECTOR APPOINTED SIMON NICHOLAS TATE
2011-07-01AP03SECRETARY APPOINTED BRENDA ELIZABETH REYNOLDS
2011-04-07NEWINCCERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72110 - Research and experimental development on biotechnology




Licences & Regulatory approval
We could not find any licences issued to CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
No legal notices or events such as winding-up orders or proposals to strike-off have been issued
Fines / Sanctions
No fines or sanctions have been issued against CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 0
Mortgages/Charges outstanding 0
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 0
Details of Mortgagee Charges
CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED does not have any mortgage charges so there is no mortgagee data available

  Average Max
MortgagesNumMortCharges0.338
MortgagesNumMortOutstanding0.178
MortgagesNumMortPartSatisfied0.001
MortgagesNumMortSatisfied0.168

This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology

Filed Financial Reports
Annual Accounts
2014-12-31
Annual Accounts
2014-09-30
Annual Accounts
2013-09-30

These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED

Intangible Assets
Patents
We have not found any records of CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED registering or being granted any patents
Domain Names
We do not have the domain name information for CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED
Trademarks
We have not found any records of CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED registering or being granted any trademarks
Income
Government Income
We have not found government income sources for CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED are:

Outgoings
Business Rates/Property Tax
No properties were found where CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Import/Export of Goods
Goods imported/exported by CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED
OriginDestinationDateImport CodeImported Goods classification description
2015-06-0170139900Glassware of a kind used for toilet, office, indoor decoration or similar purposes (excl. glassware of lead crystal or of a kind used for table or kitchen purposes, articles of heading 7018, mirrors, leaded lights and the like, lighting fittings and parts thereof, atomizers for perfume and the like)
2015-06-0070139900Glassware of a kind used for toilet, office, indoor decoration or similar purposes (excl. glassware of lead crystal or of a kind used for table or kitchen purposes, articles of heading 7018, mirrors, leaded lights and the like, lighting fittings and parts thereof, atomizers for perfume and the like)

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.